04.06.2013 Views

GHS Classification Guidance for the Japanese Government

GHS Classification Guidance for the Japanese Government

GHS Classification Guidance for the Japanese Government

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Category 1B.<br />

Mutagens classified as Category 3 (R68) in EU classification correspond to substances in<br />

Category2.<br />

D) <strong>Guidance</strong> concerning data<br />

<strong>Classification</strong> should be per<strong>for</strong>med based on data derived from appropriate in<strong>for</strong>mation<br />

sources. (Germ cell) Mutagenicity classification established by EU and classification of<br />

German MAK Committee are helpful.<br />

The mutagenicity in EU classification and <strong>the</strong> germ cell mutagenicity in <strong>GHS</strong> have <strong>the</strong><br />

same objective and classification criteria. Accordingly, test methods which can be used in EU<br />

classification can also be used in <strong>GHS</strong> classification. O<strong>the</strong>r test methods, if appropriate, can<br />

also be used.<br />

(4)<strong>Guidance</strong> <strong>for</strong> classification and judgment<br />

A) Background of this item and points to be noted<br />

Regarding <strong>the</strong> background of this item, refer to Part 1, Introduction.<br />

In classification, compare and examine all available data. It is preferable to seek <strong>for</strong> an<br />

expert's judgment about <strong>the</strong> evaluation of test results as needed. Substances having only in<br />

vitro mutagenicity data available shall, generally, be classified in "<strong>Classification</strong> not<br />

possible".<br />

* Regarding germ cell mutagenicity, refer to <strong>the</strong> UN <strong>GHS</strong> second revised edition and this<br />

item, and classify substances according to <strong>the</strong> Workflow in Decision logic 3.5.1, <strong>the</strong> UN<br />

<strong>GHS</strong> second revised edition.<br />

B) <strong>Classification</strong> Criteria<br />

Shown below are examples of test results corresponding to each <strong>GHS</strong> Category and <strong>the</strong><br />

classification workflow in Fig. 3-2 <strong>for</strong> helping classification. In <strong>the</strong> workflow, positive results<br />

fundamentally take precedence, but <strong>the</strong>ir appropriateness may be examined when needed.<br />

“Negative” results may be <strong>the</strong> result of using only one of many indexes (<strong>for</strong> example, using a<br />

part of strains in bacterial reverse mutation tests) or <strong>the</strong> result of tests conducted<br />

inappropriately (<strong>for</strong> example, inappropriate sampling time in bone marrow micronucleus test),<br />

and examination of <strong>the</strong>ir validity should be per<strong>for</strong>med when needed. On <strong>the</strong> whole, <strong>the</strong><br />

validity of each set of data is considered, and <strong>the</strong> substance is determined based on <strong>the</strong><br />

weight of evidence.<br />

1) Category 1A:When evidence from epidemioological studies in human germ cells are<br />

available:<br />

Substances whose human heritable mutagenicity was recognized by human<br />

148

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!